Yesterday | Forbes
A 10-year-old drug seems to slow aging, raising enticing questions about cancer and immunity.
Five may be more than four, but I'm not sure it's going to help GlaxoSmithKline muscle its way into the human papillomavirus vaccine space.
SchaeffersResearch.com Daily Market Blog
Call Trading Soars on Wyeth (WYE) as Sentiment Shifts
This volume is more than 12 times the stock's average daily trading volume of 11,424 contracts.
At Last, a Heartening Drug Approval
Since 2002, David and Tom Gardner have returned 28.89% while the S&P 500 returned -11.53%. Try Stock Advisor free for 30 days.
J&J pays $1B for stake in Elan
Johnson & Johnson, making a big jump into the risky but potentially lucrative field of Alzheimer's disease, is taking a major stake in Irish biopharmaceutical company Elan Corp., investing up to $1.5 billion initially.
Squeezing Blood From a Half-Dollar
Since 2002, David and Tom Gardner have returned 28.87% while the S&P 500 returned -11.51%. Try Stock Advisor free for 30 days.
Wyeth, Catalyst Biosciences, Inc. Sign Deal Worth Potentially $500 Million
COLLEGEVILLE, Pa., and SOUTH SAN FRANCISCO, Calif., June 30 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth and Catalyst Biosciences, Inc.
Wyeth Pharmaceuticals, Catalyst teaming up
Wyeth Pharmaceuticals said Tuesday that it has formed an exclusive worldwide collaboration with Catalyst Biosciences Inc.
FDA weighs options to reduce painkiller overdoses
12, 2007 file photo, Tylenol drugs are shown in the drug department at Costco in Mountain View, Calif.
M&A plunges, investment banks find money elsewhere
Mergers and acquisitions aren't delivering the fees that investment bankers used to enjoy , but fortunately, the money's coming from elsewhere.
Capital markets save dealmakers'...
Dealmakers saw business pick up again in the second quarter as they helped companies raise cash in capital markets, but lucrative mergers and acquisitions languished.
Mass. AG joins pricing suit against Wyeth
Massachusetts Attorney General Martha Coakley has joined a coalition of her peers from 14 states and Washington, D.C., in a legal complaint alleging that drug maker Wyeth failed to give the government the same discounts it offered to private payers.
Pfizer: Looking to Do Deals in Emerging Markets
Pfizer Inc will use acquisitions and partnerships in an effort to become the number one drug seller in emerging markets such as China.
Pfizer Registration Statement Relating To Pending Wyeth Acquisition Declared Effective By SEC
Pfizer Inc today announced that the U.S. Securities and Exchange Commission has declared effective Pfizer's Registration Statement on Form S-4. The Form S-4 registers with the SEC Pfizer's common stock to be issued in connection with the pending acquisition of Wyeth.
Wyeth Announces Holder Right To Surrender Convertible Debentures
Wyeth announced today that holders of Wyeth Floating Rate Convertible Senior Debentures due 2024 have the right to surrender their Convertible Debentures for purchase by Wyeth pursuant to their terms effective on the July 15, 2009 purchase date.
New program seeks to deliver vaccines to poor
Five governments and the Bill & Melinda Gates Foundation pledged $1.5 billion on Friday to help give poor countries better access to vaccines against pneumococcal disease such as pneumonia and meningitis.
You probably thought the Food and Drug Administration's slow approval process made it the only government agency that hated you.
Pfizer eyes deals to raise emerging...
Pfizer Inc , the world's largest drugmaker, is looking to conclude deals in emerging markets over "few months" to raise its share of a market estimated at about $80 billion, an executive said on Sunday.
Two Possible Upcoming Approvals for Spectrum Pharmaceuticals
Small cap drug makers are at a unique time in industry history. Over the next three years, many of big pharma's patents are set to expire.
Irving Kahn's Top Holdings: New York Community Bancorp, ScheringPlough Corp, BristolMyers ...
NYB , SGP , BMY , PFE , MRK , WYE NYB , SGP , BMY , PFE , MRK , WYE Summary Besides New York Community Bancorp Inc.